MaybergMRBatjerH: Guidelines for management of aneurysmal subarachnoid hemorrhage. Circulation90: 2592–2606, 1994.
4.
DorschNWKuigMT: A review of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Part I: Incidence and effects. J Clin Neurosci1: 19–26, 1994.
5.
CloassenJBernardiniGL: Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subaracnoid hemorrhage: the Fisher scale revisited. Stroke32: 2112–2020, 2001.
6.
Mac DonaldRL: Pathophysiology and muscolar genetics of vasospasm. Acta Neurochir Suppl48: 249–262, 2001.
7.
Treggiari-VenziMMSuterDM: Review of medical prevenction of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery48: 249–262, 2001.
8.
PlutoRMThompsonBG: Nitric Oxide and vasospasm. Acta Neurochir Suppl77: 67–72, 2001.
9.
AwardIACarterLP: Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke18: 365–372, 1987.
10.
MuizelaarJPBeckerDP: Induced hypotension for the treatment of cerebral ischemia after subarachnoid hemorrhage: direct effect on cerebral blood flow. Surg Neurol25: 317–325, 1986.
11.
RamnerBReinstrupR: Triple H therapy after aneurysmal subarachnoid hemorrhage: a rewiev. Acta Neurochir Suppl77: 237–241, 2001.
12.
LennihamLMayerSA: Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke31: 383–391, 2001.
13.
EggeAWaterlooK: Propfylactic hyperdinamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical prospective, randomized, controlled study. Neurosurgery49: 593–606, 2001.
14.
MeyerFB: Calcium antagonist and vasospasm. Neurosur Clin North Am1: 367–378, 1990.
15.
GilsbachJReulenH: Early aneurysm surgery and preventive therapy with intravenously administered nimodipine: a multicenter, double-bind, dose-comparison study. Neurosurgery26: 458–464, 1990.
16.
AuerL: Acute operation and preventive nimodipine improve outcome in patients with roptured cerebral aneurysm. Neurosurgery15: 57–66, 1984.
17.
SuzukiMDoiM: Intrathecal administration of necardipine hydrocloride to prevent vasospasm in patients with subarachnoid hemorrhage. Neurosurg Rev24: 180–184, 2001.
18.
SuzukiJOnumaT: Results of early operations on cerebral aneurysms. Surg Neurol11: 407–412, 1979.
19.
NakagomiTTakaciK: Cisternal washing therapy for the prevention of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl77: 161–165, 2001.
20.
NewellDWEskridgeJM: Angioplasty for the teatment of syntomatic vasospasm following subarachnoid hemorrhage. J Neurosurg71: 654–660, 1989.
21.
LiuJKTennerSM: Reverse of radiographically impending sroke with multiple intraarterial papaverine infusions in severe diffuse cerebral vasospasm induced by subarachnoid hemorrhage. Acta Neurochir Suppl77: 1249–1256, 2001.
22.
ShybuyaMSuzukiY: Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: results of a prospective placebo-controlled double-blind trial. J Neurosurg76: 571–577, 1992.
23.
ShybuyaMOosukaL: Clinical and angiographic effect of fasudil HCl (AT877) on cerebral vasospasm. In Cerebral Vasospasm IV, Prooceedings of the Vith Conference on Cerebral Vasospasm. Ed. SydneyDorsch N., Australia: Oslington Consulting1997: 261–263.
24.
ArakawaYKikutaK: Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases. Neurosurgery48: 723–730, 2001.
25.
DorschNWKassellNF: Metaanalysis of trials of tirilazad mesylate in aneurysmal SAH. Acta neurochir Suppl77: 233–235, 2001.
26.
Trilazad International Steering Committee: Tirizalad mesylate in acute ischemic stroke. A systematic review. Stroke31: 5257–5265, 2000.